ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)
Close on Nov 17, 2026Market cap $251.95MP/E –Yield –
ClearPoint Neuro cash
Cash and short-term investments held at the end of each period.
ClearPoint Neuro's cash was $46.18M at Sep 30, 2026. For fiscal 2025 it was $45.92M, up 128.4% from the year before. Over ten years it grew 23.8% a year on average. The highest annual figure on record is $54.11M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.92M | +128.4% |
| FY2024 | Dec 31, 2024 | $20.10M | -13.1% |
| FY2023 | Dec 31, 2023 | $23.14M | -38.3% |
| FY2022 | Dec 31, 2022 | $37.49M | -30.7% |
| FY2021 | Dec 31, 2021 | $54.11M | +169.2% |
| FY2020 | Dec 31, 2020 | $20.10M | +252.9% |
| FY2019 | Dec 31, 2019 | $5.70M | +83.7% |
| FY2018 | Dec 31, 2018 | $3.10M | -66.6% |
| FY2017 | Dec 31, 2017 | $9.29M | +180.2% |
| FY2016 | Dec 31, 2016 | $3.32M | -38.7% |
| FY2015 | Dec 31, 2015 | $5.41M | -41.5% |
| FY2014 | Dec 31, 2014 | $9.24M | +162.9% |
| FY2013 | Dec 31, 2013 | $3.52M | +117.1% |
| FY2012 | Dec 31, 2012 | $1.62M | +1013.6% |
| FY2011 | Dec 31, 2011 | $145.48K | -90.8% |
| FY2010 | Dec 31, 2010 | $1.58M | -38.6% |
| FY2009 | Dec 31, 2009 | $2.57M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $46.18M | +20.8% |
| Q2 FY2026 | Jun 30, 2026 | $29.36M | -29.3% |
| Q1 FY2026 | Mar 31, 2026 | $35.59M | +187.3% |
| Q4 FY2025 | Dec 31, 2025 | $45.92M | +128.4% |
| Q3 FY2025 | Sep 30, 2025 | $38.22M | +77.2% |
| Q2 FY2025 | Jun 30, 2025 | $41.54M | +26.5% |
| Q1 FY2025 | Mar 31, 2025 | $12.39M | -65.0% |
| Q4 FY2024 | Dec 31, 2024 | $20.10M | -13.1% |
| Q3 FY2024 | Sep 30, 2024 | $21.57M | -11.4% |
| Q2 FY2024 | Jun 30, 2024 | $32.85M | +24.1% |
| Q1 FY2024 | Mar 31, 2024 | $35.35M | +11.4% |
| Q4 FY2023 | Dec 31, 2023 | $23.14M | -38.3% |
| Q3 FY2023 | Sep 30, 2023 | $24.34M | -39.8% |
| Q2 FY2023 | Jun 30, 2023 | $26.46M | -41.4% |
| Q1 FY2023 | Mar 31, 2023 | $31.74M | -36.1% |
| Q4 FY2022 | Dec 31, 2022 | $37.49M | -30.7% |
| Q3 FY2022 | Sep 30, 2022 | $40.46M | -29.8% |
| Q2 FY2022 | Jun 30, 2022 | $45.14M | -26.6% |
| Q1 FY2022 | Mar 31, 2022 | $49.66M | -23.4% |
| Q4 FY2021 | Dec 31, 2021 | $54.11M | +169.2% |
| Q3 FY2021 | Sep 30, 2021 | $57.65M | +293.1% |
| Q2 FY2021 | Jun 30, 2021 | $61.52M | +283.8% |
| Q1 FY2021 | Mar 31, 2021 | $64.86M | +282.1% |
| Q4 FY2020 | Dec 31, 2020 | $20.10M | +252.9% |
| Q3 FY2020 | Sep 30, 2020 | $14.67M | +135.2% |
| Q2 FY2020 | Jun 30, 2020 | $16.03M | +114.9% |
| Q1 FY2020 | Mar 31, 2020 | $16.98M | +581.3% |
| Q4 FY2019 | Dec 31, 2019 | $5.70M | +83.7% |
| Q3 FY2019 | Sep 30, 2019 | $6.24M | +68.0% |
| Q2 FY2019 | Jun 30, 2019 | $7.46M | +11.4% |
| Q1 FY2019 | Mar 31, 2019 | $2.49M | -66.8% |
| Q4 FY2018 | Dec 31, 2018 | $3.10M | -66.6% |
| Q3 FY2018 | Sep 30, 2018 | $3.71M | -66.4% |
| Q2 FY2018 | Jun 30, 2018 | $6.70M | +240.0% |
| Q1 FY2018 | Mar 31, 2018 | $7.51M | +281.5% |
| Q4 FY2017 | Dec 31, 2017 | $9.29M | +180.2% |
| Q3 FY2017 | Sep 30, 2017 | $11.03M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.32M | – |
See a number that looks wrong?